The Smart Insole
Last updated on November 15th, 2015 at 12:07 pm
Wearable tech isn’t all about smartwatches and fitness bands. Sometimes it’s more important than that. With The Smart Insole, you can avoid injury and, in some cases, even surgery.
Made by UK-based bio-engineering company HCi Viocare Technologies, The Smart Insole is put into your standard-sized shoe or trainer. Its network of tiny electronic sensors will then record data and send it straight to your smartphone or tablet, where it can be analysed.
As The Smart Insole monitors the pressures and strains on your feet, it can send warnings to your smartphone to take remedial action when required.
If you don’t like the idea of a standalone device, you can also get a Smart Insole permanently put in your footwear. The product is aimed at those Joes who want to keep tabs on the condition of their feet, such as diabetic patients or athletes.
For diabetes patients, sufferers often experience neuropathy, which causes vast amounts of sensation in the feet. This means they’re more prone to foot ulcers, which could ultimately lead to amputation. Runners will also obviously benefit, as they can see how their running style impacts on their joints.
Like other wearable devices, it can also determine your weight, balance, calories expended, cadence and distance travelled. It can also be used to select corrective insoles for problems like over-pronation or tell you when your running shoes don’t give you enough support.
Christos Kapatos, Chief Technology Officer of HCi Viocare Technologies, said: “2015 is the year that both industries and individuals will truly begin to feel the impact of connectivity beyond the smartphone and PC. The Internet of Things is happening and we are already witnessing it in our everyday lives. Our Smart Insole is a great example of exactly how Internet of Things products will radically define our lives over the next decade.”
It’s not on sale yet and the company is currently engaging with potential licensing partners. But it’s expected to cost less than £200 and may be prescribed or reimbursed by healthcare providers to diabetic patients at risk of foot ulcers.